Cas no 947149-96-4 (2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one)

2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one is a heterocyclic compound featuring a fused thienopyranone scaffold with a bromine substituent at the 2-position. This structure imparts reactivity suitable for further functionalization, making it a valuable intermediate in organic synthesis, particularly for pharmaceutical and agrochemical applications. The presence of the bromine atom enhances its utility in cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, enabling the construction of complex molecular architectures. Its rigid bicyclic framework also offers potential as a building block for bioactive molecules. The compound is typically handled under inert conditions due to its sensitivity to moisture and air. High purity grades are available for research and industrial use.
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one structure
947149-96-4 structure
Product Name:2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
CAS No:947149-96-4
MF:C7H5BrO2S
MW:233.082400083542
MDL:MFCD20485646
CID:2112705
PubChem ID:68992216
Update Time:2025-06-09

2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one Chemical and Physical Properties

Names and Identifiers

    • 2-bromo-4,5-dihydro-7H-Thieno[2,3-c]pyran-7-one
    • 2-bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
    • HOFWWWORAMEEBA-UHFFFAOYSA-N
    • 2-bromo-4H,5H,7H-thieno[2,3-c]pyran-7-one
    • 2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
    • MDL: MFCD20485646
    • Inchi: 1S/C7H5BrO2S/c8-5-3-4-1-2-10-7(9)6(4)11-5/h3H,1-2H2
    • InChI Key: HOFWWWORAMEEBA-UHFFFAOYSA-N
    • SMILES: BrC1=CC2=C(C(=O)OCC2)S1

Computed Properties

  • Exact Mass: 231.91936g/mol
  • Monoisotopic Mass: 231.91936g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 0
  • Complexity: 185
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 54.5
  • XLogP3: 2.8

2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1130327-100mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4 95%
100mg
¥2613.00 2024-04-24
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1130327-250mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4 95%
250mg
¥3338.00 2024-04-24
A2B Chem LLC
AX14742-1mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4
1mg
$73.00 2024-07-18
A2B Chem LLC
AX14742-2mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4
2mg
$86.00 2024-07-18
A2B Chem LLC
AX14742-3mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4
3mg
$105.00 2024-07-18
A2B Chem LLC
AX14742-5mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4
5mg
$118.00 2024-07-18
A2B Chem LLC
AX14742-10mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4
10mg
$135.00 2024-07-18
A2B Chem LLC
AX14742-100mg
2-Bromo-4,5-dihydro-thieno[2,3-c]pyran-7-one
947149-96-4 95%
100mg
$210.00 2024-05-20
eNovation Chemicals LLC
D774793-100mg
2-BROMO-4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-ONE
947149-96-4 95%
100mg
$225 2024-06-06
Chemenu
CM424801-100mg
2-BROMO-4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-ONE
947149-96-4 95%+
100mg
$203 2023-02-01
Recommended suppliers
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.